| Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice B Lin, N Koibuchi, Y Hasegawa, D Sueta, K Toyama, K Uekawa, MJ Ma, ... Cardiovascular diabetology 13, 1-15, 2014 | 381 | 2014 |
| Accuracy of cuff-measured blood pressure: systematic reviews and meta-analyses DS Picone, MG Schultz, P Otahal, S Aakhus, AM Al-Jumaily, JA Black, ... Journal of the American College of Cardiology 70 (5), 572-586, 2017 | 268 | 2017 |
| Perindopril, a centrally active angiotensin‐converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease YF Dong, K Kataoka, Y Tokutomi, H Nako, T Nakamura, K Toyama, ... The FASEB Journal 25 (9), 2911-2920, 2011 | 166 | 2011 |
| Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion YF Dong, K Kataoka, K Toyama, D Sueta, N Koibuchi, E Yamamoto, ... Hypertension 58 (4), 635-642, 2011 | 130 | 2011 |
| Cardioprotective effects of LCZ696 (sacubitril/valsartan) after experimental acute myocardial infarction M Ishii, K Kaikita, K Sato, D Sueta, K Fujisue, Y Arima, Y Oimatsu, ... Basic to Translational Science 2 (6), 655-668, 2017 | 96 | 2017 |
| Apoptosis signal–regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion K Toyama, N Koibuchi, K Uekawa, Y Hasegawa, K Kataoka, T Katayama, ... Arteriosclerosis, thrombosis, and vascular biology 34 (3), 616-625, 2014 | 91 | 2014 |
| LCZ696, angiotensin II receptor-neprilysin inhibitor, ameliorates high-salt-induced hypertension and cardiovascular injury more than valsartan alone H Kusaka, D Sueta, N Koibuchi, Y Hasegawa, T Nakagawa, BW Lin, ... American journal of hypertension 28 (12), 1409-1417, 2015 | 86 | 2015 |
| Rosuvastatin ameliorates early brain injury after subarachnoid hemorrhage via suppression of superoxide formation and nuclear factor-kappa B activation in rats K Uekawa, Y Hasegawa, M Ma, T Nakagawa, T Katayama, D Sueta, ... Journal of Stroke and Cerebrovascular Diseases 23 (6), 1429-1439, 2014 | 71 | 2014 |
| H2FPEF Score as a Prognostic Value in HFpEF Patients D Sueta, E Yamamoto, T Nishihara, T Tokitsu, K Fujisue, F Oike, M Takae, ... American journal of hypertension 32 (11), 1082-1090, 2019 | 70 | 2019 |
| Renal denervation prevents stroke and brain injury via attenuation of oxidative stress in hypertensive rats T Nakagawa, Y Hasegawa, K Uekawa, M Ma, T Katayama, D Sueta, ... Journal of the American Heart Association 2 (5), e000375, 2013 | 65 | 2013 |
| Pretreatment with rosuvastatin protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress and inflammation M Ma, K Uekawa, Y Hasegawa, T Nakagawa, T Katayama, D Sueta, ... Brain research 1519, 87-94, 2013 | 65 | 2013 |
| Impact of statin therapy on clinical outcome in patients with coronary spasm M Ishii, K Kaikita, K Sato, K Yamanaga, T Miyazaki, T Akasaka, N Tabata, ... Journal of the American Heart Association 5 (5), e003426, 2016 | 64 | 2016 |
| Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody Y Tomita, D Sueta, Y Kakiuchi, S Saeki, K Saruwatari, S Sakata, T Jodai, ... Annals of Oncology 28 (11), 2893-2895, 2017 | 62 | 2017 |
| Long‐term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome T Katayama, D Sueta, K Kataoka, Y Hasegawa, N Koibuchi, K Toyama, ... Journal of the American Heart Association 2 (4), e000197, 2013 | 62 | 2013 |
| DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure N Koibuchi, Y Hasegawa, T Katayama, K Toyama, K Uekawa, D Sueta, ... Cardiovascular Diabetology 13, 1-11, 2014 | 61 | 2014 |
| Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis … N Tabata, D Sueta, E Yamamoto, S Takashio, Y Arima, S Araki, ... European Heart Journal-Quality of Care and Clinical Outcomes 4 (4), 290-300, 2018 | 59 | 2018 |
| Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease S Hanatani, Y Izumiya, Y Onoue, T Tanaka, M Yamamoto, T Ishida, ... International journal of cardiology 268, 216-221, 2018 | 55 | 2018 |
| Validation of the high mortality rate of Malnutrition-Inflammation-Atherosclerosis syndrome:–Community-based observational study– D Sueta, S Hokimoto, K Sakamoto, T Akasaka, N Tabata, K Kaikita, ... International journal of cardiology 230, 97-102, 2017 | 55 | 2017 |
| Assessment of platelet‐derived thrombogenicity with the total thrombus‐formation analysis system in coronary artery disease patients receiving antiplatelet therapy Y Arima, K Kaikita, M Ishii, M Ito, D Sueta, Y Oimatsu, K Sakamoto, ... Journal of Thrombosis and Haemostasis 14 (4), 850-859, 2016 | 51 | 2016 |
| Total thrombus‐formation analysis system (T‐TAS) can predict periprocedural bleeding events in patients undergoing catheter ablation for atrial fibrillation M Ito, K Kaikita, D Sueta, M Ishii, Y Oimatsu, Y Arima, S Iwashita, ... Journal of the American Heart Association 5 (1), e002744, 2016 | 49 | 2016 |
Yuichiro ArimaKumamoto University在 kumamoto-u.ac.jp 的电子邮件经过验证
